Medical Devices - Powered Exoskeletons & Rehabilitation Robotics
Strategic Profile
Myomo is positioned in the rehabilitation and assistive technology market, leveraging proprietary electromyography (EMG) technology and robotics. The company targets hospital rehabilitation centers, outpatient facilities, and home care settings, with potential for expansion into broader neurological recovery applications.
Cyborg Score Rationale
Myomo operates in a high-growth medical device segment with FDA clearance and expanding reimbursement coverage. However, the company faces typical biomedical small-cap risks including limited scale, competitive pressures from larger medical device companies, and market adoption challenges.
Top Insights
MyoPro is the only FDA-cleared wearable exoskeleton device for upper limb paralysis with expanding insurance coverage
Market opportunity for stroke and neurological injury rehabilitation is substantial and growing globally
Company has transitioned toward recurring revenue model through rental and leasing programs
Competition emerging from larger medical device manufacturers and international robotics companies
Named Competitors
Stroke Recovery Therapy — Conventional rehabilitation without powered assistance